Follow The Filings

OPTU Optimum Communications

Optimum Communications earnings company data as of 7:06 PM ET 10/30

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS -0.18 — —
Rev $1.99B — —

Insider trades

Open-market buys and sales by OPTU's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OPTU insider trades
  • $3.6M bought by 1 insider
  • $5.9M sold by 2 insiders outside a trading plan
  • $140K sold by 1 insider under 10b5-1 plans
  1. Neil S Subin 10% owner, +3 joint filers
    Buy
    $1.2M 2,228,007 shares at $0.5200 +11% to stake
    Traded Oct 22–23 Filed Oct 26
    ↗
  2. Neil S Subin 10% owner, +3 joint filers
    Buy
    $2.5M 3,032,354 shares at $0.8100 +18% to stake
    Traded Jul 29–Aug 25 Filed Oct 9
    ↗
  3. Michael Olsen General Counsel and CCRO
    Planned sale
    $15K 20,000 shares at $0.7400 2.3% of stake
    Traded Aug 3 Filed Aug 5
    ↗
  4. Michael Olsen General Counsel and CCRO
    Planned sale
    $18K 20,000 shares at $0.8800 2.2% of stake
    Traded Jul 1 Filed Jul 1
    ↗
  5. Michael Olsen General Counsel and CCRO
    Planned sale
    $22K 20,000 shares at $1.12 2.1% of stake
    Traded Jun 1 Filed Jun 2
    ↗
  6. Michael Olsen General Counsel and CCRO
    Planned sale
    $32K 20,000 shares at $1.59 1.6% of stake
    Traded May 1 Filed May 4
    ↗
  7. Michael Olsen General Counsel and CCRO
    Planned sale
    $26K 20,000 shares at $1.29 1.6% of stake
    Traded Apr 1 Filed Apr 3
    ↗
  8. Michael Olsen General Counsel and CCRO
    Planned sale
    $28K 20,000 shares at $1.40 1.6% of stake
    Traded Mar 2 Filed Mar 3
    ↗
  9. Michael Olsen General Counsel and CCRO
    Sale
    $400K 250,000 shares at $1.60 14% of stake
    Traded Feb 17 Filed Feb 19
    ↗
  10. Dexter Goei Director
    Sale
    $2.7M 1,514,182 shares at $1.77 20% of stake
    Traded Dec 9–10 Filed Dec 11, 2025
    ↗
  11. Dexter Goei Director
    Sale
    $665K 349,582 shares at $1.90 4.4% of stake
    Traded Dec 5, 2025 Filed Dec 9, 2025
    ↗
  12. Dexter Goei Director
    Sale
    $426K 223,915 shares at $1.90 2.7% of stake
    Traded Dec 3–4 Filed Dec 5, 2025
    ↗
  13. Dexter Goei Director
    Sale
    $417K 217,126 shares at $1.92 2.6% of stake
    Traded Dec 1–2 Filed Dec 3, 2025
    ↗
  14. Dexter Goei Director
    Sale
    $1.3M 695,195 shares at $1.90 7.6% of stake
    Traded Nov 26, 2025 Filed Dec 1, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 10 sales back to the company and 9 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 2.02,4.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 3.01,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,3.02,7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.